MRVI peer analysis
Maravai LifeSciences (MRVI) against its competitors: price, today's move, 1-year return and market value side by side.
MRVI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AZTA Azenta | $39.00 | 4.33% | 23.43% | – |
| BIO Bio-Rad | $381.57 | 3.41% | 18.61% | $10.16B |
| LAB Standard BioTools | $0.62 | 1.04% | -48.24% | – |
| NEOG Neogen | $11.76 | 0.68% | 93.21% | $2.72B |
| PACB Pacific Biosciences | $2.25 | -7.33% | 21.00% | $792.62M |
| RGEN Repligen | $173.49 | 2.97% | 14.58% | $11.39B |
| TECH Bio-Techne | $72.78 | 0.17% | 18.94% | $11.42B |
| MRVI Maravai LifeSciences | $7.67 | 9.89% | 141.81% | – |
- MRVI's peers: AZTA (Azenta), BIO (Bio-Rad), LAB (Standard BioTools), NEOG (Neogen), PACB (Pacific Biosciences), RGEN (Repligen), TECH (Bio-Techne).
Updated 2026-11-07 11:55 UTC